is mounjaro a glp-1 medication Weight Loss Injection/ Could GLP-1 Weight Loss Drugs

No injections

The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers.

With rising interest in gut health and hormone balance, products likeSupergut GLP-1 Boosterhave gained significant attention

What many users don't realize is that dehydration and electrolyte depletion drive most of these symptomsand the righ

The CMS GLP-1 Bridge program is a notable step forward in expanding access to obesity treatments for Medicare beneficiaries